Skip to main content

Table 1 Baseline characteristics

From: Feasibility and safety of reprocessing of intracardiac echocardiography catheters for electrophysiology procedures – a large single center experience

 

N = 1128

Demographic variables

 Male gender, n (%)

797 (70.6%)

 Age at the time of procedure, years (mean ± SD)

57.9 ± 13.2

 BMI, kg/m2 (mean ± SD)

28.4 ± 4.2

Main diagnosis

 Atrial fibrillation, n (%)

954 (84.5%)

 Supraventricular tachycardia, n (%)

81 (7.2%)

 Atrial flutter, n (%)

9 (0.8%)

 Premature ventricular contractions, n (%)

23 (2.1%)

 Ventricular tachycardia, n (%)

61 (5.4%)

Comorbidities

 Hypertension, n (%)

727 (64.4%)

 Diabetes, n (%)

123 (10.9%)

 Ischemic heart disease, n (%)

137 (12.1%)

 Heart failure, n (%)

182 (16.1%)

 Chronic renal failure (eGFR < 60 mL/min), n (%)

87 (7.7%)

 Previous TIA/stroke n (%)

57 (5.1%)

Echocardiography parameters

 LA diameter, mm (mean ± SD)

40.1 ± 4.2

 LVEF, % (mean ± SD)

58.6 ± 10.4

Anticoagulant/antiplatelet therapy

 SAPT/DAPT

101 (8.9%)

 VKA

143 (12.6%)

 DOAC

742 (65.8%)

  1. BMI body mass index, DAPT dual antiplatelet therapy, eGFR estimated glomerular flow rate, LA left atrium, LVEF left ventricular ejection fraction, SAPT single antiplatelet therapy, TIA transient ischemic stroke, VKA vitamin K antagonists